REGN241108C1230000
- 0.00
- 0.000.00%
Regeneron Pharmaceuticals Newsroom
Assessing Regeneron Pharmaceuticals's Performance Against Competitors In Biotechnology Industry
Regeneron Pharma Is Maintained at Outperform by Oppenheimer
Regeneron Pharmaceuticals Analyst Ratings
Oppenheimer Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,000
Sanofi, Regeneron Receive European Pediatric Approval for Throat Disease Treatment
Express News | Regeneron - Dupixent (Dupilumab) Approved in European Union as First and Only Medicine for Young Children With Eosinophilic Esophagitis
Truist Financial Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Announces Target Price $1,126
Regeneron Pharmaceuticals Insider Sold Shares Worth $844,610, According to a Recent SEC Filing
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Bernstein Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,110
This Is What Whales Are Betting On Regeneron Pharmaceuticals
Piper Sandler Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,195
TD Cowen Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,230
TD Cowen Reaffirms Their Buy Rating on Regeneron (REGN)
A Quick Look at Today's Ratings for Regeneron Pharmaceuticals(REGN.US), With a Forecast Between $800 to $1,195
Regeneron Pharma Is Maintained at Buy by Truist Securities
Bernstein Adjusts Price Target on Regeneron Pharmaceuticals to $1,110 From $1,135
Piper Sandler Maintains Overweight on Regeneron Pharmaceuticals, Lowers Price Target to $1195
This month, US stocks bull stock | soared 5 times in a year! MSTR plans to finance 42 billion to continue to increase its holdings of bitcoin; Explosive growth of users! The "American Tieba" Reddit soared more than 40% after the performance.
This month, the Dow Jones Industrial Average fell by 0.9% to 41,763.46 points; meanwhile, the S&P 500 Index declined by 1.86% to 5,705.45 points during the same period. The Nasdaq Index also saw a cumulative decline of 2.76% to 18,095.15 points.